Clovis Oncology Inc (CLVS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5500 FLATIRON PARKWAY BOULDER, CO 80301

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.

Data as of 2021-08-02 08:17:33 -0400
Market Cap505.049 Million Shares Outstanding104.565 Million Avg 30-day Volume4.532 Million
P/E Ratio-1.50242 Dividend Yield EPS-3.64
Price/Sales3.16 Debt to Equity-2.48 EBITDA-272.879 Million
Price to Book Value-2.28 Forward PE-0.08 Enterprise Value942.727 Million
Total Cash190.922 Million Current Debt173.236 Million Gross Profit124.711 Million
BETA1.11093 52-week High/Low11.1 / 4.08 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9.1472
Data provided by IEX Cloud
View SEC Filings from CLVS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 2 (0.12%) 0 (0.0%)
Funds Holding: 162 158 2.53% 43 (2.52%) 45 (2.61%) -4.44%
13F shares: 49.988 Million 55.071 Million -9.23% 15.083 Million 18.614 Million -18.97%
% Ownership 47.8218 53.2442 -10.18% 14.4297 17.9969 -19.82%
New Positions: 38 25 52.0% 13 11 18.18%
Increased Positions 45 50 -10.0% 13 16 -18.75%
Closed Positions 31 35 -11.43% 15 7 114.29%
Reduced Positions 43 44 -2.27% 11 11 0.0%
Total Calls 2.631 Million 3.935 Million -33.14% 800.4 Thousand 1.048 Million -23.61%
Total Puts 4.791 Million 5.391 Million -11.12% 885.1 Thousand 1.189 Million -25.56%
PUT/CALL Ratio 1.82 1.37 32.85% 1.11 1.13 -1.77%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

26 total shares from 1 transactions

Exercise Derivative Conversion (M)

63 total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SIMANTOV RONIT

  • Director
0 2021-07-12 2

HARDING THOMAS C. SEE REMARKS

  • Officer
3,184 2021-07-01 11

ATWOOD BRIAN G

  • Director
42,223 2021-06-10 2

SPICKSCHEN THORLEF

  • Director
42,223 2021-06-10 1

MCKINLEY EDWARD J

  • Director
42,223 2021-06-10 1

BLAIR JAMES C

  • Director
42,223 2021-06-10 1

KLINGENSTEIN PAUL H

  • Director
42,223 2021-06-10 1

FLAHERTY KEITH T.

  • Director
42,223 2021-06-10 1

GRAHAM GINGER L

  • Director
42,223 2021-06-10 1

FAIR RICHARD A.

  • Director
42,223 2021-06-10 1

AZELBY ROBERT

  • Director
42,223 2021-06-10 1

IVERS-READ GILLIAN C SEE REMARKS

  • Officer
502,156 2021-06-01 10

ROLFE LINDSEY SEE REMARKS

  • Officer
149,589 2021-06-01 10

MUEHL DANIEL W SEE REMARKS

  • Officer
112,535 2021-06-01 8

GROSS PAUL EDWARD SEE REMARKS

  • Officer
100,443 2021-06-01 7

MAHAFFY PATRICK J SEE REMARKS

  • Officer
  • Director
380,000 2021-03-01 1

BARRETT M JAMES

  • Director
0 2018-10-11 0

FAIR RICHARD A.

FAIR RICHARD A.

  • Director
0 2018-10-11 1

HOOKS CORWIN DALE SEE REMARKS

  • Officer
5,349 2018-09-05 0

MAST ERLE T EXECUTIVE VP AND CFO

  • Officer
135,583 2015-11-02 0

HOERTER STEVEN L. SEE REMARKS

  • Officer
0 2015-03-05 0

ALLEN ANDREW R SEE REMARKS

  • Officer
0 2015-03-02 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
44,034 2013-06-04 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
2,581,745 2013-06-04 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
No longer subject to file 2013-06-03 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2013-06-03 0

KOLLURI KRISHNA KITTU

  • 10% Owner
No longer subject to file 2013-06-03 0

KERINS PATRICK J

  • 10% Owner
No longer subject to file 2013-06-03 0

DRANT RYAN D

  • 10% Owner
No longer subject to file 2013-06-03 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2013-06-03 0

WELLER HARRY R

  • 10% Owner
No longer subject to file 2013-06-03 0

VISWANATHAN RAVI

  • 10% Owner
No longer subject to file 2013-06-03 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2013-06-03 0

MOTT DAVID M

  • 10% Owner
No longer subject to file 2013-06-03 0

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
No longer subject to file 2013-06-03 0

NEW ENTERPRISE ASSOCIATES 13 LP

  • 10% Owner
No longer subject to file 2013-06-03 0

REED JOHN C

  • Director
0 2012-06-14 0

DOMAIN PARTERS VII L P

  • 10% Owner
2,990,937 2011-11-21 0

DOVEY BRIAN H

  • 10% Owner
3,041,950 2011-11-21 0

HALAK BRIAN K

  • 10% Owner
3,041,950 2011-11-21 0

TREU JESSE I

  • 10% Owner
3,041,950 2011-11-21 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
3,041,950 2011-11-21 0

VITULLO NICOLE

  • 10% Owner
3,041,950 2011-11-21 0

DP VII ASSOCIATES LP

  • 10% Owner
51,013 2011-11-21 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA 13 GP, LTD

NEA PARTNERS 13, LIMITED PARTNERSHIP

  • 10% Owner
3,419,671 2011-11-21 0

KRAMLICH C RICHARD

  • 10% Owner
3,419,671 2011-11-21 0

DOMAIN ASSOCIATES

  • 10% Owner
32,758 2011-11-15 0

KAMDAR KIM P.

  • 10% Owner
32,758 2011-11-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SIMANTOV RONIT - Director

2021-07-13 16:25:24 -0400 2021-07-12 A 83,212 a 83,212 direct

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-07-06 16:16:04 -0400 2021-07-01 M 63 a 187 indirect

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-07-06 16:16:04 -0400 2021-07-01 S 26 $5.79 d 1,272 indirect 0.0 -1.8553 0.5566 3 -2.0408 5

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-07-06 16:16:04 -0400 2021-07-01 M 63 a 1,298 indirect 0.0 -1.8553 0.5566 3 -2.0408 5

FAIR RICHARD A. - Director

2021-06-11 20:48:39 -0400 2021-06-10 A 42,223 a 42,223 direct

AZELBY ROBERT - Director

2021-06-11 21:07:52 -0400 2021-06-10 A 42,223 a 42,223 direct

SPICKSCHEN THORLEF - Director

2021-06-11 21:08:33 -0400 2021-06-10 A 42,223 a 42,223 direct

MCKINLEY EDWARD J - Director

2021-06-11 20:56:22 -0400 2021-06-10 A 42,223 a 42,223 direct

KLINGENSTEIN PAUL H - Director

2021-06-11 21:05:42 -0400 2021-06-10 A 42,223 a 42,223 direct

BLAIR JAMES C - Director

2021-06-11 21:02:16 -0400 2021-06-10 A 42,223 a 42,223 direct

ATWOOD BRIAN G - Director

2021-06-11 20:51:42 -0400 2021-06-10 A 42,223 a 42,223 direct

FLAHERTY KEITH T. - Director

2021-06-11 21:02:15 -0400 2021-06-10 A 42,223 a 42,223 direct

GRAHAM GINGER L - Director

2021-06-11 20:54:37 -0400 2021-06-10 A 42,223 a 42,223 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CLOVIS ONCOLOGY INC CLVS 2021-08-03 15:15:03 UTC -0.8016 0.8616 300000
CLOVIS ONCOLOGY INC CLVS 2021-08-03 14:45:04 UTC -0.8016 0.8616 300000
CLOVIS ONCOLOGY INC CLVS 2021-08-03 14:15:03 UTC -0.8016 0.8616 300000
CLOVIS ONCOLOGY INC CLVS 2021-08-03 13:45:03 UTC -0.8016 0.8616 300000
CLOVIS ONCOLOGY INC CLVS 2021-08-03 13:15:03 UTC -0.8016 0.8616 300000
CLOVIS ONCOLOGY INC CLVS 2021-08-03 12:45:03 UTC -0.8016 0.8616 250000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 22:15:03 UTC -0.8016 0.8616 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 21:45:03 UTC -0.8016 0.8616 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 21:15:03 UTC -0.8016 0.8616 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 20:45:03 UTC -0.8023 0.8623 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 20:15:03 UTC -0.8023 0.8623 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 19:45:03 UTC -0.8023 0.8623 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 19:15:03 UTC -0.8023 0.8623 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 18:45:03 UTC -0.986 1.046 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 18:15:03 UTC -0.986 1.046 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 17:45:03 UTC -0.986 1.046 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 17:15:03 UTC -0.986 1.046 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 16:45:03 UTC -1.0798 1.1598 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 16:15:03 UTC -1.0798 1.1598 500000
CLOVIS ONCOLOGY INC CLVS 2021-08-02 15:45:03 UTC -1.0798 1.1598 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Multi-Strategy Alternative Fund CLVS -4996.0 shares, $-29126.68 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CLVS -32400.0 shares, $-227448.0 2021-03-31 N-PORT

Elevate your investments